Research programme: leptin agonists - BioLineRx

Drug Profile

Research programme: leptin agonists - BioLineRx

Alternative Names: BL-N010; EDP 21

Latest Information Update: 27 Sep 2013

Price : $50

At a glance

  • Originator BioLineRx
  • Class Recombinant proteins
  • Mechanism of Action Leptin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Obesity

Most Recent Events

  • 27 Sep 2013 Early research is ongoing in Israel
  • 03 Mar 2011 Early research in Obesity in Israel (unspecified route)
  • 13 Feb 2007 Discontinued - Preclinical for Obesity in Israel (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top